Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial)

Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products

(2011) Bo Feng et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Rapid, Direct Effects of Statin Treatment on Arterial Redox State and Nitric Oxide Bioavailability in Human Atherosclerosis via Tetrahydrobiopterin-Mediated Endothelial Nitric Oxide Synthase Coupling

(2011) Charalambos Antoniades et al.   CIRCULATION

Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over study

(2011) Ana María Wägner et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis

(2011) Ting-Ting Tang et al.   JOURNAL OF LIPID RESEARCH

Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial

(2011) Stephan Martin et al.   PLoS One

Immunological and Cardiometabolic Risk Factors in the Prediction of Type 2 Diabetes and Coronary Events: MONICA/KORA Augsburg Case-Cohort Study

(2011) Christian Herder et al.   PLoS One

Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels

(2010) Ilze Bot et al.   ATHEROSCLEROSIS

Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes: Whitehall II Prospective Cohort Study

(2010) M. Carstensen et al.   DIABETES

Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-β signal transduction

(2010) Yong Chan Kim et al.   IMMUNOLOGY

Statin-induced Kruppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses

(2010) De-xiu Bu et al.   JOURNAL OF CLINICAL INVESTIGATION

Statins attenuate high mobility group box-1 protein induced vascular endothelial activation : a key role for TLR4/NF-κB signaling pathway

(2010) Jun Yang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Increased plasma interleukin-1 receptor antagonist levels in men with visceral obesity

(2009) Amélie Cartier et al.   ANNALS OF MEDICINE

Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study

(2009) C. Herder et al.   DIABETOLOGIA

Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes

(2009) F. Montecucco et al.   RHEUMATOLOGY

The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis

(2008) A. Blum et al.   ATHEROSCLEROSIS

Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of  -Cell Function in Therapeutic Trials in Type 1 Diabetes

(2008) C. J. Greenbaum et al.   DIABETES CARE

Dual mode of HMG-CoA reductase inhibition on dendritic cell invasion

(2007) Sieglinde Kofler et al.   ATHEROSCLEROSIS